Avoro Capital is a global life sciences investment firm based in New York, NY, that specializes in supporting emerging biotechnology companies. With a comprehensive approach, they seek out scientific breakthroughs to address unmet medical needs and provide financial and intellectual support throughout the investment lifecycle. Their vigilant risk management strategy includes assessing macro and company-specific risks, employing tactical and fundamental hedges, and carefully considering sizing and liquidity.
As the biotechnology sector undergoes unprecedented transformation, Avoro Capital embraces the challenge of advancing novel therapies and partnering with large pharmaceutical firms to drive progress. Their focus on identifying unique or mispriced investment opportunities reflects their commitment to fostering innovation in the field. With a strong emphasis on thoughtful investing, Avoro Capital aims to contribute to the advancement of biopharmaceutical innovation.
Generated from the website